DARE logo

Daré Bioscience, Inc. (DARE)

Profile

Full Name

Daré Bioscience, Inc.

Ticker

NASDAQ: DARE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 10, 2014

Indexes

Not included

Website

https://darebioscience.com

Employees

21

Key Details

Price

$2.12(+4.43%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9800.00(-99.65% YoY)

Annual EPS

-$0.48(+88.43% YoY)

PE ratio

-

Next earnings date

Aug 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.12
    DARE price is $2.12

    30-Day Relative Volume

    0.26
    DARE 30-day relative volume is 0.26

    Price Performance

    Price Today change

    +4.43%
    DARE price is up +4.43% today

    Price YTD change

    -32.05%
    DARE price is down -32.05% since January 1st

    Price 1-year change

    -49.52%
    DARE price is down -49.52% year-on-year

    Price 3-year change

    -85.52%
    DARE price is down -85.52% over the past 3 years

    Price Range

    Price All-time high

    $1304.40
    DARE price is currently -99.84% below its historical high of $1304.40

    Price 3-year low

    $1.83
    DARE price is currently +15.85% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $18.76M
    DARE market capitalization is $18.76 million

    Market cap 3-year change

    -81.87%
    DARE market capitalization is down -81.87% over the past 3 years

    Market cap All-time high

    $217.21M
    DARE market capitalization is currently -91.36% below its historical high of $217.21 million

    Market cap sector rank

    22.37%
    DARE market capitalization is higher than 22.37% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.56%
    DARE shares outstanding is up +3.56% year-on-year

    Shares Outstanding 3-Year Change

    +25.21%
    DARE shares outstanding is up +25.21% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.34
    DARE beta is 0.34

    200-day SMA

    $3.04
    DARE price is currently -30.22% below its 200-day simple moving average

    50-day SMA

    $2.63
    DARE price is currently -19.41% below its 50-day simple moving average

    RSI

    33.41
    DARE 14-day relative strength index is 33.41

    Volume

    0.26
    DARE 30-day relative volume is 0.26

    ATR

    $0.22
    DARE average true range is $0.22

    10-day Historical Volatility

    67.09%
    DARE 10-day historical volatility is 67.09%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $9800.00
    DARE annual revenue is $9800.00

    Revenue Analysts estimate

    $839.61K
    DARE annual revenue is currently -98.83% lower than the consensus analysts' forecast

    Revenue 1-year change

    -99.65%
    DARE annual revenue is down -99.65% year-on-year

    Revenue Sector rank

    1.96%
    DARE annual revenue is higher than 1.96% of companies in Healthcare sector

    EPS

    EPS

    -$0.48
    DARE annual earnings per share is -$0.48

    EPS Analysts estimate

    -$2.20
    DARE annual earnings per share is currently -78.21% lower than the consensus analysts' forecast

    EPS 1-year change

    +88.43%
    DARE annual earnings per share is up +88.43% year-on-year

    EPS Sector rank

    67.81%
    DARE annual earnings per share is higher than 67.81% of companies in Healthcare sector

    Profit

    Gross profit

    -
    DARE annual gross profit value is unknown

    Gross margin

    -
    DARE annual gross profit margin value is unknown

    Operating profit

    -$23.45M
    DARE annual operating income is -$23.45 million

    Operating margin

    -239.69K%
    DARE annual operating profit margin is -239.69 thousand%

    Net income

    -$4.05M
    DARE annual net profit is -$4.05 million

    Net margin

    -41.43K%
    DARE annual net profit margin is -41.43 thousand%

    Expenses

    Total expenses

    $23.46M
    DARE annual total expenses is $23.46 million

    Operating expenses

    $23.46M
    DARE annual total operating expenses is $23.46 million

    Cost of goods sold

    -
    DARE annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $9.16M
    DARE annual SGA is $9.16 million

    Depreciation and amortization

    $42.30K
    DARE annual depreciation & amortization is $42.30 thousand

    Interest expense

    -
    DARE annual interest expense value is unknown

    Income tax

    -
    DARE annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$23.45M
    DARE annual earnings before interest & taxes is -$23.45 million

    EBITDA

    -$23.41M
    DARE annual EBITDA is -$23.41 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $22.10M
    DARE annual total assets is $22.10 million

    Non current assets

    $3.65M
    DARE annual long term assets is $3.65 million

    Current assets

    $18.45M
    DARE annual total current assets is $18.45 million

    Cash and cash equivalents

    $15.70M
    DARE annual cash & cash equivalents is $15.70 million

    Accounts receivable

    -
    DARE annual accounts receivable value is unknown

    Inventory

    -
    DARE annual inventory value is unknown

    Liabilities

    Total liabilities

    $28.11M
    DARE annual total liabilities is $28.11 million

    Long term liabilities

    $6.50M
    DARE annual total long term liabilities is $6.50 million

    Current liabilities

    $21.61M
    DARE annual total current liabilities is $21.61 million

    Accounts payable

    $1.46M
    DARE annual accounts payable is $1.46 million

    Debt

    Total debt

    $1.30M
    DARE annual total debt is $1.30 million

    Total debt 1-year change

    -7.22%
    DARE annual total debt is down -7.22% year-on-year

    Long term debt

    $754.40K
    DARE annual long term debt is $754.40 thousand

    Short term debt

    $548.60K
    DARE annual short term debt is $548.60 thousand

    Equity & Capital

    Shareholders equity

    -$6.01M
    DARE annual stockholders equity is -$6.01 million

    Book value

    -$6.01M
    DARE annual book value is -$6.01 million

    Retained earnings

    -$175.29M
    DARE annual retained earnings is -$175.29 million

    Working capital

    -$3.16M
    DARE annual working capital is -$3.16 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $5.39M
    DARE annual cash flow from operations is $5.39 million

    Cash from operations 1-year change

    +113.88%
    DARE annual cash flow from operations is up +113.88% year-on-year

    Cash from investing

    -$573.00K
    DARE annual cash flow from investing activities is -$573.00 thousand

    Cash from investing 1-year change

    +8.96%
    DARE annual cash flow from investing activities is up +8.96% year-on-year

    Cash from financing

    $433.80K
    DARE annual cash flow from financing activities is $433.80 thousand

    Cash from financing 1-year change

    -97.23%
    DARE annual cash flow from financing activities is down -97.23% year-on-year

    CAPEX

    CAPEX

    $573.00K
    DARE annual capital expenditures is $573.00 thousand

    CAPEX 1-year change

    -8.96%
    DARE annual capital expenditures is down -8.96% year-on-year

    Free Cash Flow

    Free cash flow

    $4.82M
    DARE annual free cash flow is $4.82 million

    Free cash flow 1-year change

    +112.21%
    DARE annual free cash flow is up +112.21% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    DARE annual gross profit margin value is unknown

    Operating margin

    -239.69K%
    DARE annual operating profit margin is -239.69 thousand%

    Net margin

    -41.43K%
    DARE annual net profit margin is -41.43 thousand%

    ROA & ROE

    ROA

    -18.69%
    DARE annual return on assets is -18.69%

    ROE

    67.42%
    DARE annual return on equity is 67.42%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DARE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DARE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -1.96
    DARE price to book ratio is -1.96

    PB ratio Sector rank

    8.06%
    DARE price to book ratio is higher than 8.06% of companies in Healthcare sector

    PS Ratio

    PS ratio

    724.43
    DARE price to sales ratio is 724.43

    PS ratio Sector rank

    98.78%
    DARE price to sales ratio is higher than 98.78% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $12.01M
    DARE enterprise value is $12.01 million

    Enterprise value Sector rank

    20.7%
    DARE enterprise value is higher than 20.7% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.55
    DARE EV/EBITDA is -0.55

    EV/EBITDA Sector rank

    55.9%
    DARE EV/EBITDA is higher than 55.9% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.85
    DARE annual current ratio is 0.85

    Quick ratio

    -
    DARE annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    DARE annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    DARE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    DARE piotroski f-score value is unknown

    Altman Z-Score

    -14.38
    DARE altman z-score is -14.38

    Analyst ratings

    Recent major analysts updates

    Apr 1, 25 HC Wainwright & Co.
    Buy
    Dec 17, 24 HC Wainwright & Co.
    Buy
    Nov 15, 24 HC Wainwright & Co.
    Buy
    Oct 24, 24 HC Wainwright & Co.
    Buy
    Aug 16, 24 Jones Trading
    Buy
    Aug 14, 24 Maxim Group
    Hold
    May 15, 24 HC Wainwright & Co.
    Buy
    May 15, 24 Brookline Capital
    Buy
    May 1, 24 HC Wainwright & Co.
    Buy
    Apr 17, 24 Brookline Capital
    Hold

    Institutional Ownership

    Screeners with DARE included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Daré Bioscience, Inc.?
    • Does Daré Bioscience, Inc. pay dividends?
    • What sector is Daré Bioscience, Inc. in?
    • What industry is Daré Bioscience, Inc. in?
    • What country is Daré Bioscience, Inc. based in?
    • When did Daré Bioscience, Inc. go public?
    • Is Daré Bioscience, Inc. in the S&P 500?
    • Is Daré Bioscience, Inc. in the NASDAQ 100?
    • Is Daré Bioscience, Inc. in the Dow Jones?
    • When was Daré Bioscience, Inc.'s last earnings report?
    • When does Daré Bioscience, Inc. report earnings?

    What is the ticker symbol for Daré Bioscience, Inc.?

    The ticker symbol for Daré Bioscience, Inc. is NASDAQ:DARE

    Does Daré Bioscience, Inc. pay dividends?

    No, Daré Bioscience, Inc. does not pay dividends

    What sector is Daré Bioscience, Inc. in?

    Daré Bioscience, Inc. is in the Healthcare sector

    What industry is Daré Bioscience, Inc. in?

    Daré Bioscience, Inc. is in the Biotechnology industry

    What country is Daré Bioscience, Inc. based in?

    Daré Bioscience, Inc. is headquartered in United States

    When did Daré Bioscience, Inc. go public?

    Daré Bioscience, Inc.'s initial public offering (IPO) was on April 10, 2014

    Is Daré Bioscience, Inc. in the S&P 500?

    No, Daré Bioscience, Inc. is not included in the S&P 500 index

    Is Daré Bioscience, Inc. in the NASDAQ 100?

    No, Daré Bioscience, Inc. is not included in the NASDAQ 100 index

    Is Daré Bioscience, Inc. in the Dow Jones?

    No, Daré Bioscience, Inc. is not included in the Dow Jones index

    When was Daré Bioscience, Inc.'s last earnings report?

    Daré Bioscience, Inc.'s most recent earnings report was on May 13, 2025

    When does Daré Bioscience, Inc. report earnings?

    The next expected earnings date for Daré Bioscience, Inc. is August 14, 2025
    On this page